Company profile: Alleviant Medical
1.1 - Company Overview
Company description
- Provider of transcatheter technology to lift the clinical and economic burden of heart failure, offering the Alleviant System to treat chronic heart failure by creating a connection between the heart's atrial chambers without leaving a permanent implant, and conducting the ALLAY-HF pivotal trial plus clinical evidence programs evaluating safety, effectiveness, and patient outcomes.
Products and services
- ALLAY-HF Study: Pivotal trial evaluating safety and efficacy of the Alleviant System in heart failure patients remaining symptomatic despite medical therapy, collecting patient outcomes to characterize post-treatment effectiveness
- Alleviant System: Transcatheter device treating chronic heart failure by creating a connection between the heart’s atrial chambers, delivering therapy without leaving a permanent implant for implant-free, catheter-based intervention
- Clinical Evidence: Clinical research and data collection on safety, effectiveness, and patient outcomes following Alleviant System use, compiling evidence to inform heart failure care with an implant-free atrial connection therapy
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Alleviant Medical
Medyria
HQ: Switzerland
Website
- Description: Provider of sensor-based medical devices for cardiovascular catheter navigation and sensing, based on proprietary Blood Flow Velocity Sensor technology. Products include TrackCath for minimally invasive endovascular and EVAR procedures with real-time catheter positioning and blood flow velocity data, and PyCath for real-time monitoring of key physiological parameters during interventional cardiology procedures.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medyria company profile →
Avantec Vascular
HQ: United States
Website
- Description: Provider of coronary and peripheral vascular medical devices, including the Duraflex Coronary Stent System for vascular disease treatment, Apollo Coronary Dilatation Catheter, Captus Vascular Retrieval System for retrieving foreign objects (guide wires, coils, balloons, catheters, filters), neurovascular and peripheral coils, peripheral atherectomy, and specialty coronary/peripheral drug-eluting stents.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Avantec Vascular company profile →
Advanced Circulatory
HQ: United States
Website
- Description: Provider of intrathoracic pressure regulation products designed to help restore life and improve the quality of life for patients experiencing cardiac arrest, low blood pressure, and head injury. Serves military, emergency medical services, and hospital markets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Advanced Circulatory company profile →
Axon Therapies
HQ: United States
Website
- Description: Provider of neuromodulation-based heart failure solutions, including SAVM (Splanchnic Ablation for Volume Management), a procedure that ablates the right greater splanchnic nerve to reduce sympathetic activity, normalize volume balance, and improve heart function in HFpEF; the catheter-based Axon Ablation System delivering targeted ablation via the femoral vein; and Rebalance-HF studies evaluating SAVM safety and efficacy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Axon Therapies company profile →
Percutaneous Valve Technologies
HQ: United States
Website
- Description: Provider of medical devices for delivering heart valves to treat late-stage aortic stenosis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Percutaneous Valve Technologies company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Alleviant Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Alleviant Medical
2.2 - Growth funds investing in similar companies to Alleviant Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Alleviant Medical
4.2 - Public trading comparable groups for Alleviant Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →